RxDoctor Payments Data

Jeffrey Segal, MD

Urogynecology and Reconstructive Pelvic Surgery · Livingston, NJNPI 1780652990

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Boston Scientific at 41.1% of the total. Reporting peaked in 2024 at $371 and has fallen 67.3% since, to $121 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in NJ, where the typical reported total is $3,953.

$1,087in general payments, 2019–2025

Across 15 payments — averaging $72.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$446
  • Coloplast$426
  • Axonics, Inc.$85
  • Applied Medical Resources Corporation$61
  • Neotract Inc.$27
  • ABC Home Medical Supply, Inc.$21
  • plus $21 from 1 others

What the payments were for

  • Food & beverage$1,087100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific5$446
Coloplast3$426
Axonics, Inc.3$85
Applied Medical Resources Corporation1$61
Neotract Inc.1$27
ABC Home Medical Supply, Inc.1$21
Hollister Incorporated1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,087 in reported general payments places this provider in the 15th percentile of 35 urogynecology and reconstructive pelvic surgery providers in New Jersey.

See all urogynecology and reconstructive pelvic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$214,954
Medicare patients
436
Services billed
3,061

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron382$330,656
GemtesaVibegron361$312,621
Estradiol312$18,759
Mirabegron ErMirabegron26$14,887
PremarinEstrogens, Conjugated31$13,044
Trospium Chloride ErTrospium Chloride71$9,775
Darifenacin ErDarifenacin Hydrobromide37$6,178
Methenamine Hippurate67$4,753
Solifenacin Succinate59$3,857
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst154$1,703
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip28$577
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim43$138
Fluconazole17$112
Cephalexin19$70
Ciprofloxacin Hcl13$49

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Livingston

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →